Skip to main content
. 2016 Feb 1;18(4):375–383. doi: 10.1111/dom.12619

Figure 2.

DOM-12619-FIG-0002-b

Clinical measures across the 6‐month study period in the modified intention‐to‐treat (mITT) population: (A) glycated haemoglobin (HbA1c), (B) laboratory‐measured fasting plasma glucose (FPG), (C) average pre‐injection self‐monitored plasma glucose (SMPG) profile and (D) daily basal and mealtime insulin dose. Data are shown as mean ± standard error. Gla‐100, insulin glargine 100 U/ml; Gla‐300, insulin glargine 300 U/ml; BL, baseline; W, week; M, month; LOCF, last observation carried forward.